Two Code Sets, One Big Update: FY 2027 ICD-10-CM/PCS
More diagnosis choices, procedure technology, and reasons to read the documentation closely.
Effective October 1, 2026, the FY 2027 update introduces 190 new ICD-10-CM codes, 30 deletions, and 4 revisions, along with 101 new ICD-10-PCS codes, 38 deletions, and 3 revisions.
Here, we’ll connect the most significant changes across both code sets and identify what coding professionals should do.
ICD-10-CM Code Updates
The clearest theme is greater clinical specificity. New diagnosis choices distinguish secondary malignancies of the larynx, pharynx, and oral cavity; post-bariatric hypoglycemia from other postprocedural hypoglycemia; and familial-genetic dilated cardiomyopathy from other forms of dilated cardiomyopathy.
Pregnancy coding also becomes more specific, with distinct codes for interstitial, cesarean-scar, cervical, and cornual ectopic pregnancies. Depending on the condition, the record may need to identify laterality, the presence or absence of an intrauterine pregnancy, the exact site, or the relationship to a prior procedure.
The update also creates new ways to represent complex genetic conditions. Category QA1 identifies genetic disorders associated with neoplasms, including QA1.71 Lynch syndrome, BRCA1- and BRCA2-associated familial cancer syndromes, and Li-Fraumeni syndrome. These codes don’t replace the need to report an applicable malignancy, personal history, or site-specific genetic susceptibility when the classification directs it. The diagnosis must be clearly documented as an inherited syndrome rather than inferred from family history, testing results, or a risk-management plan alone.
Several CM changes may affect severity reporting. New code J4B, Pulmonary mycetoma, includes pulmonary fungal ball and carries an instruction to code the associated infection when it’s known. The coder should not assume aspergillosis merely because it’s a common cause of pulmonary mycetoma; the responsible infection must be documented.
New codes K6A.01, Prevesical abscess, and K6A.09, Other pelvic abscess, requiring attention to related conditions and the infectious agent when known.
J4B, K6A.01, and K6A.09 are identified as new MCCs in the code set, while expanded neoplasm, cardiomyopathy, postprocedural hypoglycemia, osteomyelitis, ectopic pregnancy, and other codes add new CC options. Severity status may change the MS-DRG, but it never substitutes for a clinically supported, reportable diagnosis.
ICD-10-PCS Code Changes
The guideline changes reinforce a familiar rule: construct the code from what was actually performed. Guidelines A6 and A7 clarify that the Alphabetic Index helps locate the appropriate table. However, consulting the Index first is not required; a valid code may be selected directly from the tables. Guideline B3.3 directs the coder to report the root operation performed when a procedure is discontinued. If the procedure stops before another root operation occurs, code Inspection of the body part or anatomical region inspected.
Guideline B3.4a identifies lymph-node sampling for biopsy as Excision with the Diagnostic qualifier, and B3.5 confirms that procedures involving overlapping musculoskeletal layers are coded to the deepest layer reached.
The new PCS codes also show how quickly inpatient technology is changing. The code set includes new options for transcatheter and size-adjustable valves, aortic-arch and peripheral vascular stent systems, carbon/PEEK spinal stabilization devices, gene therapy, imaging and navigation systems, and software that supports early recognition of STEMI, sepsis, cardiac arrest risk, and other urgent findings.
One especially notable addition is XW0337C, Introduction of Zimislecel allogeneic stem cell-derived islet cell therapy into a peripheral vein, percutaneous approach, New Technology Group 12. Product name, route, approach, device or substance, and whether the procedure was actually completed must all be supported before assigning a product-specific New Technology code.
Application of Code Sets
To apply both code sets, consider this case. A patient with type 1 diabetes and recurrent level 2 hypoglycemia is admitted for Zimislecel therapy. The provider documents the diabetes and its manifestations, while the procedure note and pharmacy record identify the product and confirm percutaneous infusion through peripheral venous access. The coder assigns the applicable ICD-10-CM code(s) supported by the final diagnostic statement (E10.649 and E16.A2) and validates XW0337C in the PCS table. If the Zimislecel introduction is the only reportable procedure, an additional Administration code is not assigned merely to describe the same infusion. If the record identifies only “stem-cell therapy,” however, the coder should not assume the product-specific PCS value.
First, an expanded code set increases the need for precise provider language. Terms that were once adequate may no longer support the most specific diagnosis, body part, product, approach, or technology value. Second, code changes must be paired with operational updates. Organizations should revise encoders, coding references, CDI tip sheets, queries, audit tools, and severity logic before October 1, then monitor early FY2027 cases for unsupported specificity, missed tabular instructions, duplicate PCS reporting, and outdated CC/MCC edits.
The Bottom Line
The FY2027 update is more than a collection of new codes. ICD-10-CM asks coding professionals to capture more precise clinical distinctions, while ICD-10-PCS asks them to translate increasingly complex procedures and technologies without losing sight of the core guidelines. The best preparation is simple: review the complete record, verify every code in the current files, follow all applicable instructions, and query when the documentation cannot support the level of detail now available.
Want a more in depth review of these code changes? Watch the recap of the FY2027 ICD-10-CM/PCS Code Updates Webinar.
Looking for your next opportunity in coding? Harmony Healthcare has been matching qualified job seekers with careers that match their goals for more than 15 years. Check out our open jobs page today!
This article is by Dianna Foley, RHIA, CCS, CDIP, CHPS, External Education Partner/Consultant
